NASDAQ:VACH Voyager Acquisition (VACH) Stock Price, News & Analysis $10.31 -0.01 (-0.10%) As of 05/23/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Voyager Acquisition Stock (NASDAQ:VACH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Voyager Acquisition alerts:Sign Up Key Stats Today's Range$10.31▼$10.3150-Day Range$10.17▼$10.3252-Week Range$9.95▼$11.20Volume105 shsAverage Volume126,033 shsMarket Capitalization$326.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVoyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y.Read More… Receive VACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyager Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address VACH Stock News HeadlinesVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | globenewswire.comVoyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 6, 2025 | finanznachrichten.deA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. May 24, 2025 | Porter & Company (Ad)VERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5, 2025 | finanznachrichten.deVeraxa to go public in $1.6bn SPAC deal with VoyagerApril 23, 2025 | msn.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVeraxa Biotech to merge with SPAC Voyager in $1.64 billion dealApril 23, 2025 | msn.comSee More Headlines VACH Stock Analysis - Frequently Asked Questions How have VACH shares performed this year? Voyager Acquisition's stock was trading at $10.02 on January 1st, 2025. Since then, VACH stock has increased by 2.9% and is now trading at $10.31. View the best growth stocks for 2025 here. Who are Voyager Acquisition's major shareholders? Top institutional investors of Voyager Acquisition include AQR Arbitrage LLC (4.49%), Wolverine Asset Management LLC (4.46%), Westchester Capital Management LLC (3.99%) and Schechter Investment Advisors LLC (2.18%). How do I buy shares of Voyager Acquisition? Shares of VACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:VACH CIK2006815 WebN/A Phone347-720-2907FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,625,000Free FloatN/AMarket Cap$326.05 million OptionableN/A BetaN/A 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:VACH) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.